Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A CCR2+ myeloid cell niche required for pancreatic β cell growth
Kristin Mussar, Stephanie Pardike, Tobias M. Hohl, Gary Hardiman, Vincenzo Cirulli, Laura Crisa
Kristin Mussar, Stephanie Pardike, Tobias M. Hohl, Gary Hardiman, Vincenzo Cirulli, Laura Crisa
View: Text | PDF
Research Article Development Endocrinology

A CCR2+ myeloid cell niche required for pancreatic β cell growth

  • Text
  • PDF
Abstract

Organ-specific patterns of myeloid cells may contribute tissue-specific growth and/or regenerative potentials. The perinatal stage of pancreas development marks a time characterized by maximal proliferation of pancreatic islets, ensuring the maintenance of glucose homeostasis throughout life. Ontogenically distinct CX3CR1+ and CCR2+ macrophage populations have been reported in the adult pancreas, but their functional contribution to islet cell growth at birth remains unknown. Here, we uncovered a temporally restricted requirement for CCR2+ myeloid cells in the perinatal proliferation of the endocrine pancreatic epithelium. CCR2+ macrophages are transiently enriched over CX3CR1+ subsets in the neonatal pancreas through both local expansion and recruitment of immature precursors. Using CCR2-specific depletion models, we show that loss of this myeloid population leads to a striking reduction in β cell proliferation, dysfunctional islet phenotypes, and glucose intolerance in newborns. Replenishment of pancreatic CCR2+ myeloid compartments by adoptive transfer rescues these defects. Gene profiling identifies pancreatic CCR2+ myeloid cells as a prominent source of IGF2, which contributes to IGF1R-mediated islet proliferation. These findings uncover proproliferative functions of CCR2+ myeloid subsets and identify myeloid-dependent regulation of IGF signaling as a local cue supporting pancreatic proliferation.

Authors

Kristin Mussar, Stephanie Pardike, Tobias M. Hohl, Gary Hardiman, Vincenzo Cirulli, Laura Crisa

×

Figure 10

Transcriptional profiling of CCR2+ myeloid subsets.

Options: View larger image (or click on image) Download as PowerPoint
Transcriptional profiling of CCR2+ myeloid subsets.
(A) Heatmaps of sele...
(A) Heatmaps of select genes differentially expressed in CD11b+CCR2+ myeloid cells sorted from P0 and E14.5 pancreas as compared with those sorted from P0 spleen, as reference. Scales on top of each gene cluster show the range of changes (bright red = highest; black = lowest). (B) Validation of differentially expressed IGF-related transcripts by RT-PCR. (C) RT-PCR of IGF2 mRNA detected in sorted CCR2+ myeloid cells isolated from P0 spleen and pancreas (red bars) versus that measured in whole mesenchymal and epithelial fractions of E14.5 and P0 pancreas or CD45–CD31–EpCAM+ cells sorted from P10 islets (mean ± SEM of triplicate samples normalized to 18S). Representative of n = 2. (D) IGF2 immunoreactivity in pancreatic sections of P10 CCR2RFP/WT mice highlights CCR2+RFP+ cells (arrowheads). Scale bars: 30 μm (top row) and 20 μm (bottom row). Representative of n = 3 experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts